Centre news

Professor Sarah Tabrizi, Director of the UCL Huntington’s Disease Centre, has been awarded the British Neuroscience Association (BNA) Outstanding Contribution to Neuroscience Award for 2025, the association’s top annual prize.

A global clinical trial for a new Huntington’s disease treatment has posted positive results today, announced by trial sponsor uniQure and UCL scientists.

A series of digital tests, carried out via a smartphone app, could enhance the detection of disease progression in Huntington’s disease and improve the efficiency of clinical trials, finds research led by scientists at UCL and Roche.

In a major new project, Prof Gabriel Balmus and Prof Sarah Tabrizi aim to selectively target DNA repair pathways, to develop disease modifying therapies for Huntington’s.

We're delighted that Dr Mena Farag (UCL Queen Square Institute of Neurology) was awarded the UK DRI PhD Prize on 9th December 2025 at Connectome 2025.

Professor Sarah Tabrizi (UCL Queen Square Institute of Neurology) has been named in Nature's 10 list, recognising the people involved in the most influential and important developments this year.